QP-Breast assists radiologists during the interpretation of breast MRI studies by providing accurate detection of lesions suspicious for breast cancer and generating clear, user-friendly reports that slot into existing hospital systems.

Breast cancer remains the most commonly diagnosed cancer in women globally, with 2.3 million new cases each year. This figure continues to rise, with global incidence expected to increase significantly over the coming decades. As MRI plays a growing role in screening and diagnosis, particularly for high-risk patients and those with dense breast tissue, radiology teams are under increasing strain.